Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2007
10/17/2007EP1844765A1 Contraception and hormone replacement therapy comprising a combination of estrogene with cholesterol and progesterone
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1153034B1 Growth hormone secretagogues
10/17/2007CN101056862A Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
10/17/2007CN101054364A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (ER) ligands and their use in the treatmentof inflammarory diseases
10/17/2007CN101053629A Traditional Chinese medicine preparations for treating luteal phase defect sterility
10/17/2007CN101053620A Traditional Chinese medicine preparations for treating luteal phase defect sterility
10/17/2007CN101053613A Traditional Chinese medicine preparations for treating luteal phase defect sterility
10/17/2007CN101053610A Traditional Chinese medicine preparations for treating luteal phase defect sterility
10/17/2007CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
10/17/2007CN100342908C Pharmaceutical form of administration for peptides, method for its production and use
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery
10/16/2007CA2336654C Plaster which contains steroids, and a method for the production and use thereof
10/11/2007WO2006064277A8 Silicon compounds and their use
10/11/2007US20070238762 Use of Antagonists of Hepatic Sympathetic Nerve Activity
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238749 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
10/11/2007US20070238714 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
10/11/2007US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007DE102005059222B4 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen 11ß-Benzaldoximderivate of D-Homoestra-4,9-dien-3-ones
10/10/2007EP1842552A1 Treatment for diabetes
10/10/2007EP1842543A1 Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
10/10/2007EP1841780A2 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
10/10/2007EP1841731A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
10/10/2007EP1841723A1 Decaline derived compounds as pharmaceutically active agents
10/10/2007EP1841421A1 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
10/10/2007EP1381608B1 Cyclohexylphenyl vasopressin agonists
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007CN101052397A 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists
10/10/2007CN101049329A Application of angelica oil in raising level of estradiol from internal source for treating estradiol related disease
10/10/2007CN100341578C Anhydrous topical skin preparations
10/09/2007US7279600 Drugs as hormone substitutes for biopolymers or prodrugs
10/09/2007US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279293 Constitutively active histamine H3 receptor mutants and uses thereof
10/04/2007WO2007112280A1 Methods and compositions for making and using polymorphs of cinacalcet
10/04/2007WO2007111921A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007WO2007110226A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/04/2007WO2007109857A1 Agent for the treatment of hormone-dependent disorders and uses thereof
10/04/2007WO2007109852A1 Selenium for treatment of cancer
10/04/2007WO2007082726A3 Flowable leuprolide-containing composition for treating inflammation-mediated neurodegenerative diseases
10/04/2007WO2007076144A3 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
10/04/2007WO2006030306A8 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007US20070232696 Valproic acid and derivatives thereof as histone deacetylase inhibitors
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232571 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
10/04/2007US20070231272 Process for Preparing Inhalable Powders
10/04/2007US20070231269 Analgesics
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007CA2645494A1 Methods and compositions for making and using polymorphs of cinacalcet
10/04/2007CA2645487A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007CA2642880A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers
10/03/2007EP1304324B1 Serotonin reuptake inhibitors
10/03/2007EP1272471B1 Non-steroidal, tetracyclic compounds for estrogen-related treatments
10/03/2007CN101048381A Novel imidazolidine derivative and use thereof
10/03/2007CN101045166A Pulmonary administration of chemically modified insulin
10/03/2007CN101045155A Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
10/03/2007CN101045048A Application of chondriosome nutrient composition for preventing and treating insulin resistance and biabetes
10/03/2007CN101045034A Bioadhesive drug delivery system
10/03/2007CN100340573C Heterocarpine, human GHRH-binding protein
10/03/2007CN100340572C Novel LHRH antagonist
10/03/2007CN100340188C Pure natural health food with lactagogue action
10/02/2007US7276533 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth
10/02/2007CA2378369C Small molecules useful in the treatment of inflammatory disease
10/02/2007CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
09/2007
09/27/2007WO2007062874B1 Sulfamoyl sulfonate prodrugs
09/27/2007WO2006076317A9 Aminophenyl derivatives as selective androgen receptor modulators
09/27/2007US20070225352 methyl-[3-(2-nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indol-6-yl]-amine, possessing androgenic activity are useful in androgen-related treatments such as male hypogonadism, male and female hormone replacement therapy and male contraception
09/27/2007US20070225349 Substituted 4-(Indazol-3-yl)phenols
09/27/2007US20070225296 Arylalkylamine Compound and Process for Preparing the Same
09/27/2007US20070225218 Extracellular Messengers
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/26/2007EP1836215A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
09/26/2007EP1836202A2 Aminophenyl derivatives as selective androgen receptor modulators
09/26/2007EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy
09/26/2007EP1153131B1 Compositions for gene therapy of diabetes
09/26/2007EP1140960B1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
09/26/2007CN101044131A Androgen modulators
09/26/2007CN101041016A Medicine for curing pituitary adenoma and its preparation method
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 290